Drug Trial Radar · NCT03129100
A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis
Last checked: Nov 20, 2026Latest source record: Jun 13, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
773
Actual
Start
May 9, 2017
Primary completion
May 26, 2020
Study completion May 27, 2021
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Apr 26, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate, in participants having achieved a state of sustained remission, if the ixekizumab treatment groups are superior to the placebo group in maintaining response during the randomized withdrawal-retreatment period in participants with axial spondyloarthritis.
Conditions
- Axial Spondyloarthritis
Interventions
IxekizumabDrug
Administered SC
PlaceboDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Who do Not Experience a Flare (Combined Ixekizumab Treatment)Time frame: Week 64
Locations
127 sites in 23 countries. Site status is shown where the registry gives one.
Arizona Arthritis & Rheumatology Research
Phoenix, Arizona
Care Access Research - Huntington Beach
Huntington Beach, California
Desert Medical Advances
Palm Desert, California
Arthritis Assoc. & Osteoporosis Ctr of Colorado Springs, LLC
Colorado Springs, Colorado
Clinical Research Center of CT/NY
Danbury, Connecticut
Arthritis Rheumatic Disease Specialties
Aventura, Florida
Sarasota Arthritis Center
Sarasota, Florida
Marietta Rheumatology
Marietta, Georgia
Institute of Arthritis Research
Idaho Falls, Idaho
Center for Arthritis & Osteoporosis
Elizabethtown, Kentucky
Klein and Associates MD, PA
Cumberland, Maryland
Klein and Associates MD, PA
Hagerstown, Maryland
Arthritis Consultants Inc.
St Louis, Missouri
Glacier View Research Institute
Kalispell, Montana
Physician Research Collaboration, LLC
Lincoln, Nebraska
Shanahan Rheumatology & Immunotherapy, PLLC
Raleigh, North Carolina
Carolina Arthritis Associates
Wilmington, North Carolina
Oregon Health and Science University
Portland, Oregon
Altoona Center for Clinical Research
Duncansville, Pennsylvania
Articularis Healthcare Group, INC dba Columbia Arthritis Ctr
Columbia, South Carolina
Articularis Healthcare d/b/a/ Low Country Rheumatology, PA
Summerville, South Carolina
Univ of Texas Health Science Center - Houston
Houston, Texas
Arthritis Northwest PLLC
Spokane, Washington
Consultorios Reumatologicos Pampa
Ciudad Autonoma de Buenos Aire, Argentina
CIR Centro de Investigacions Reumatologicas
San Miguel de Tucumán, Argentina
Clinica Adventista de Belgrano
Ciudad de Buenos Aires, Buenos Aires, Argentina
CER Instituto Medico
Quilmes, Buenos Aires, Argentina
Centro de Enfermedades del Higado y Aparato Digestivo
Rosario, Santa Fe Province, Argentina
Centro Medico Privado de Reumatologia
San Miguel de Tucumán, Tucumán Province, Argentina
KH der Barmherzigen Schwestern Wien BetriebsGesmbH
Vienna, Austria
CIP - Centro Internacional de Pesquisa
Goiás, Brazil
CMIP - Centro Mineiro de Pesquisa
Juiz de Fora, Minas Gerais, Brazil
EDUMED - Educação em Saúde Ltda.
Curitiba, Paraná, Brazil
CCBR Brasil Centro de Analises e Pesquisas Clínicas LTDA
Rio de Janeiro, Rio de Janeiro, Brazil
Hospital de Clinicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
LMK Serviços Médicos S/S
Porto Alegre, Rio Grande do Sul, Brazil
Cpclin Centro de Pesquisas Clinicas
São Paulo, São Paulo, Brazil
Group de recherche en maladies osseuses
Québec, Canada
University of Alberta Hospital
Edmonton, Alberta, Canada
St. Clare's Mercy Hospital
St. John's, Newfoundland and Labrador, Canada
Showing 40 of 127 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.